Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8509316 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL2636631 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL15263324 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL2010790 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL4436402 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL5182595 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL240028 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL9393256 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| Water SCHEMBL5144372 | 0.99 | HIF1A (0.42) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL7643809 | 0.90 | PYGL (0.38) | HIF1AADORA2AADORA2BLMNANT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024233957-A2 | COMPOSITIONS AND METHODS TO PREVENT, INHIBIT OR TREAT NEURODEGENERATIVE DISEASES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2024-11-14 | — | — | WO | disclosed |
| WO-2024112568-A1 | ANTISENSE OLIGOMER (ASO) AS AN INHIBITOR OF LIVER FIBROSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-30 | — | — | WO | disclosed |
| WO-2017136757-A1 | USE OF ADENOSINE RECEPTOR SIGNALING TO REGULATE P-GP FUNCTION | CORNELL UNIVERSITY (US) | 2017-08-10 | — | — | WO | disclosed |
| EP-2516637-B1 | THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS | PLASMIA BIOTECH S L (ES) | 2016-04-20 | — | — | EP | disclosed |
| US-8759034-B2 | Thermostable biocatalyst combination for nucleoside synthesis | PLASMIA BIOTECH, S.L. (ES) | 2014-06-24 | — | — | US | disclosed |
| US-20130337547-A1 | THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS | BRILL ENGINES, S.L. (ES) | 2013-12-19 | — | — | US | disclosed |
| US-8512997-B2 | Thermostable biocatalyst combination for nucleoside synthesis | PLASMIA BIOTECH, S.L. (ES) | 2013-08-20 | — | — | US | disclosed |
| EP-2516637-A1 | THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS | Plasmia Biotech, S.L. (ES) | 2012-10-31 | — | — | EP | disclosed |
| US-20120264175-A1 | THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS | BRILL ENGINES, S.L. (ES) | 2012-10-18 | — | — | US | disclosed |
| WO-2011076894-A1 | THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS | INSTITUT UNIV. DE CIÈNCIA I TECNOLOGIA, S.A. (ES) | 2011-06-30 | — | — | WO | disclosed |
| WO-2008063727-A2 | COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONS | UNITED THERAPEUTICS CORPORATION (US) | 2008-05-29 | — | — | WO | disclosed |
| EP-1879907-A1 | NOVEL ADENYL DINUCLEOTIDES WITH ANTITUMOUR ACTIVITY AND A METHOD FOR PREPARING THEREOF | UNIVERSITA DEGLI STUDI DI GENOVA (IT) | 2008-01-23 | — | — | EP | disclosed |
| WO-2006117735-A1 | NOVEL ADENYL DINUCLEOTIDES WITH ANTITUMOUR ACTIVITY AND A METHOD FOR PREPARING THEREOF | UNIVERSITA' DEGLI STUDI DI GENOVA (IT) | 2006-11-09 | — | — | WO | disclosed |
| EP-0869809-A1 | CYTOKINE AND HEMOPOIETIC FACTOR ENDOGENOUS PRODUCTION ENHANCER AND METHODS OF USE THEREOF | Balazovsky, Mark Borisovich (RU) | 1998-10-14 | — | — | EP | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| WO-1997021444-A9 | CYTOKINE AND HEMOPOIETIC FACTOR ENDOGENOUS PRODUCTION ENHANCER AND METHODS OF USE THEREOF | — | 1997-10-30 | — | — | WO | disclosed |
| WO-1997021444-A1 | CYTOKINE AND HEMOPOIETIC FACTOR ENDOGENOUS PRODUCTION ENHANCER AND METHODS OF USE THEREOF | BALAZOVSKY MARK BORISOVICH (RU) | 1997-06-19 | — | — | WO | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| CN-1029968-C | Process for preparation of N-heteroaryl-purin-6-amines and their use as medicaments | HOECHST ROUSSEL PHARMA (US) | 1995-10-11 | — | — | CN | disclosed |
| US-5070877-A | Using adenosin receptor agonist | MEDCO RESEARCH, INC. (US) | 1991-12-10 | — | — | US | disclosed |